New tablet form aims to protect kidneys in transplant patients
Disease control
Not yet recruiting
This study is testing if switching stable liver transplant patients from their regular entecavir pill to a new dissolving tablet version is safe and effective. The main goal is to see if the new tablet helps protect the patients' kidney function over 48 weeks. Researchers will al…
Phase: PHASE2 • Sponsor: Jongman Kim • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC